VIATRIS (MYLAN, INC)

Lobbying client · Pennsylvania · filed 2025 to 2026

Generics and specialty pharmaceutical company

$420,000 Reported spend

8 Filings counted

1 Outside firm hired

5 Bills named

Spend is reported income plus in-house expenses across 8 filings. 2 further filings for this client were restated by a later amendment and are left out of every total here. Everything on this page comes from one LDA client record (66077), filed by the registrant listed below.

Who filed for this client 1

S-3 GROUP $420,000 Outside firm · 8 filings

Spend per registrant: fees an outside firm reported, or the costs the client reported for lobbying in-house. The rows add up to the total above.

Bills named in these filings 5

H.R. 1843
To amend the Federal Food, Drug, and Cosmetic Act to increase transparency in generic drug applications.

8 filings
S. 1302
Increasing Transparency in Generic Drug Applications Act

8 filings
S. 1041
Affordable Prescriptions for Patients Act

6 filings
S. 1096
Preserve Access to Affordable Generics and Biosimilars Act

6 filings
S. 527
Prescription Pricing for the People Act of 2025

6 filings

Reported by year 2 years

2026 $180,000 3 filings
2025 $240,000 5 filings

Issues lobbied 2

The count is how many filings named that issue area. A filing reports one lump figure covering every issue on it, so the money above cannot be split between them.

Agencies and chambers lobbied 2

HOUSE OF REPRESENTATIVES 7
SENATE 7

Recent filings 10 total

Q3 report

S-3 GROUP

3rd Quarter 2026 (July 1 - Sep 30) · House · Senate · $60,000 income · posted Oct 16, 2026

View → Q2 report

S-3 GROUP

2nd Quarter 2026 (Apr 1 - June 30) · House · Senate · $60,000 income · posted Jul 17, 2026

View → Q1 report

S-3 GROUP

1st Quarter 2026 (Jan 1 - Mar 31) · House · Senate · $60,000 income · posted Apr 17, 2026

View → Q4 amendment

S-3 GROUP

4th Quarter 2025 (Oct 1 - Dec 31) · House · Senate · $60,000 income · posted Jan 20, 2026

View → Q4 report

S-3 GROUP Amended

4th Quarter 2025 (Oct 1 - Dec 31) · House · Senate · $60,000 income · posted Jan 15, 2026

View → Q3 report

S-3 GROUP

3rd Quarter 2025 (July 1 - Sep 30) · House · Senate · $60,000 income · posted Oct 20, 2025

View → Q2 report

S-3 GROUP

2nd Quarter 2025 (Apr 1 - June 30) · House · Senate · $60,000 income · posted Jul 18, 2025

View → Q1 amendment

S-3 GROUP

1st Quarter 2025 (Jan 1 - Mar 31) · House · Senate · $60,000 income · posted Apr 21, 2025

View → Q1 report

S-3 GROUP Amended

1st Quarter 2025 (Jan 1 - Mar 31) · House · Senate · $40,000 income · posted Apr 21, 2025

View → Registration

S-3 GROUP

1st Quarter 2025 (Jan 1 - Mar 31) · posted Apr 21, 2025

View →

Keep going

Filings through October 16, 2026, the newest posted date on this record. Source: federal Lobbying Disclosure Act filings, synced daily. Money is self-reported by the filer and often rounded. Lobbying is legal, disclosed activity.